RN

Ravindra Narendranath Walawalkar

Active Director Director DIN 09390670
DIN 09390670 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravindra Narendranath Walawalkar

Data last updated:

Ravindra Narendranath Walawalkar is a Director at Alakhniranjan Healthcare Private Limited (since 2021). The company operates in Healthcare.

DIN 09390670
Primary Designation Director
Industry Healthcare
First Appointment 09 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Nov 20212021Active

Board colleagues of Ravindra Narendranath Walawalkar

Directorship timeline

Open interactive timeline →
Alakhniranjan Healthcare Private Limited
Premium access

Shareholding and investment profile for Ravindra Narendranath Walawalkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindra Narendranath Walawalkar

Ravindra Narendranath Walawalkar currently holds 1 directorship: Alakhniranjan Healthcare Private Limited (Director, since 09 Nov 2021).

Ravindra Narendranath Walawalkar was first appointed on 09 Nov 2021 as Director at Alakhniranjan Healthcare Private Limited.

The current boards of Ravindra Narendranath Walawalkar's companies include Poorva Sagar Deshpande (Alakhniranjan Healthcare Private Limited), Sagar Nandkumar Deshpande (Alakhniranjan Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available